Does Incompatibility Matter? Comparative Outcomes Following Treatment of Early AMR in ABO-Incompatible (Aboi) Renal Transplants

被引：0
|
作者：
Mahendran, A. O. [1 ]
Mohan, S. [2 ]
Watkins, A. C. [1 ]
Loftus-Farren, K. J. [1 ]
Stokes, M. B. [3 ]
Crew, J. [2 ]
Cohen, D. [2 ]
Herlitz, L. [3 ]
Vasilescu, E. -R. M. [3 ]
Ratner, L. E. [1 ]
机构：
[1] Columbia Univ, Ctr Abdominal Transplantat, New York, NY USA
[2] Columbia Univ, Nephrol, New York, NY USA
[3] Columbia Univ, Pathol & Cell Biol, New York, NY USA
来源：
TRANSPLANTATION | 2012年 / 94卷 / 10期
关键词：
D O I：
10.1097/00007890-201211271-02104
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
2272
引用
收藏
页码：1061 / 1061
页数：1
相关论文
共 7 条
  • [1] A Mouse Model for ABO-Incompatible Transplantation (ABOi Tx): Study of Antibody-Mediated Rejection (AMR) Following ABOi Heart Tx
    Motyka, B.
    Rahman, F.
    Kratochvil, A.
    Tao, K.
    Pearcey, J.
    Marshall, T.
    Sis, B.
    Mengel, M.
    Fisicaro, N.
    d'Apice, A.
    Cowan, P.
    West, L.
    TRANSPLANTATION, 2014, 98 : 390 - 390
  • [2] A Mouse Model for ABO-Incompatible Transplantation (ABOi Tx): Study of Antibody-Mediated Rejection (AMR) Following ABOi Heart Tx
    Motyka, B.
    Rahman, F.
    Kratochvil, A.
    Tao, K.
    Pearcey, J.
    Marshall, T.
    Sis, B.
    Mengel, M.
    Fisicaro, N.
    d'Apice, A.
    Cowan, P.
    West, L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 390 - 390
  • [3] Early Antibody-Mediated-Rejection in ABO-Incompatible Renal Transplant Recipients Can Be Successfully Treated with Comparable Clinical Outcomes to ABO-Compatible Transplants
    Mahendran, A. O.
    Mohan, S.
    Watkins, A. C.
    Stokes, M. B.
    Crew, J.
    Cohen, D.
    Ratner, L. E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 418 - 418
  • [4] Early Outcomes of Single Dose Eculizumab for Abo-Incompatible Living Donor Renal Transplantation.
    Heagler, K.
    Campara, M.
    Di Cocco, P.
    Gaitonde, S.
    Tang, I.
    Alvarez, J. Almario
    Spaggiari, M.
    Benken, J.
    Muran, C. S.
    Valdepenas, B.
    Pierce, D.
    Tzvetanov, I.
    Benedetti, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 1087 - 1087
  • [5] Three-Year Outcomes Following 1420 ABO-Incompatible Living-Donor Kidney Transplants Performed After ABO Antibody Reduction: Results From 101 Centers
    Opelz, Gerhard
    Morath, Christian
    Suesal, Caner
    Thuong Hien Tran
    Zeier, Martin
    Doehler, Bernd
    TRANSPLANTATION, 2015, 99 (02) : 400 - 404
  • [6] A comparative study on outcomes of ABO-incompatible kidney transplants between robot-assisted vs. open surgery-propensity score-matched analysis: a retrospective cohort study
    Kim, Jin-Myung
    Kwon, Hye Eun
    Ko, Youngmin
    Jung, Joo Hee
    Kwon, Hyunwook
    Kim, Young Hoon
    Shin, Sung
    BMC NEPHROLOGY, 2024, 25 (01)
  • [7] A 46-Year-Old Thai Woman with Secondary Acquired Pure Red Cell Aplasia Due to Treatment with Recombinant Erythropoietin While on Dialysis for End-Stage Renal Disease Who Recovered Following ABO-Incompatible Kidney Transplantation
    Kitpermkiat, Rungthiwa
    Thotsiri, Sansanee
    Arpornsujaritkun, Nuttaporn
    Sangkum, Premsant
    Chantrathammachart, Pichika
    Kitpoka, Pimpun
    Thammanichanond, Duangtawan
    Virankabutra, Tanist
    Kantachuvesiri, Surasak
    AMERICAN JOURNAL OF CASE REPORTS, 2022, 23
1